Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2025-12-25 @ 8:21 PM
Study NCT ID:
NCT01159769
Status:
COMPLETED
Last Update Posted:
2012-04-03
First Post:
2010-07-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis
Sponsor:
Alcon Research
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06
Start Date Type:
None
Primary Completion Date:
2010-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-08
Completion Date Type:
ACTUAL
First Submit Date:
2010-07-08
First Submit QC Date:
None
Study First Post Date:
2010-07-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-03-05
Results First Submit QC Date:
None
Results First Post Date:
2012-04-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-03-05
Last Update Post Date:
2012-04-03
Last Update Post Date Type:
ESTIMATED